SO
SURF

STRS Ohio’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

STRS Ohio’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-133,500
Closed -$638K – 2266
2021
Q4 		$638K Buy
133,500
+11,900
+10% +$76.8K ﹤0.01% 1396
2021
Q3 		$920K Buy
121,600
+13,600
+13% +$87K ﹤0.01% 1153
2021
Q2 		$805K Buy
+108,000
New +$832K ﹤0.01% 1330
2019
Q2 		– Sell
-32,400
Closed -$129K – 2234
2019
Q1 		$154K Hold
32,400
– – ﹤0.01% 1726
2018
Q4 		$137K Buy
32,400
+17,800
+122% +$137K ﹤0.01% 1705
2018
Q3 		$159K Buy
14,600
+12,500
+595% +$146K ﹤0.01% 1752
2018
Q2 		$34K Buy
+2,100
New +$30.4K ﹤0.01% 2024

Other funds holding SURF

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

STRS Ohio's SURF Position: Q1 2022 in Review

STRS Ohio sold out of Surface Oncology, Inc. Common Stock (SURF) in Q1 2022, closing a stake of 133,500 shares — an estimated $638K sold.

STRS Ohio first reported a position in SURF in Q2 2018 and held it in 7 quarters. The position peaked at $920K in Q3 2021. 103 funds tracked by Wall St. Rank hold SURF as of Q1 2022.

  • STRS Ohio reported no remaining Surface Oncology, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • STRS Ohio sold 133,500 Surface Oncology, Inc. Common Stock shares in Q1 2022, an estimated $638K.
  • STRS Ohio first reported a position in Surface Oncology, Inc. Common Stock in Q2 2018 and held it in 7 quarters.
  • STRS Ohio's Surface Oncology, Inc. Common Stock position peaked at $920K in Q3 2021.
  • 103 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q1 2022.

Based on STRS Ohio's 13F filing for Q1 2022, filed 21 Apr 2022.